arrow_back Back to App

Global Strategy for Pandemic and Superbug Product Development (SUPER BUGS Act)

This Act mandates the Secretary of State to formulate a global strategy to secure international support for developing and commercializing products against pandemics and antimicrobial-resistant pathogens (superbugs). The goal is to enhance global health security by ensuring faster, coordinated development of new drugs, vaccines, and diagnostics. This unified approach aims to prevent duplication of effort and efficiently allocate resources to protect citizens from future health crises.
Key points
Enhanced Health Security: Focuses on accelerating the development of products to combat pandemic-potential pathogens and superbugs, directly improving public health protection.
International Collaboration: Requires the U.S. government to enter into arrangements with foreign countries and multilateral organizations to jointly fund, develop, and distribute new medical countermeasures.
Efficient Resource Allocation: The strategy must ensure that scarce funds are allocated to projects with the greatest positive impact on human health, including through public-private partnerships and streamlined regulatory processes.
Addressing Superbugs: Specifically targets antimicrobial-resistant pathogens, aligning with existing U.S. biodefense and antibiotic resistance strategies.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_4581
Sponsor: Sen. Kelly, Mark [D-AZ]
Process start date: 2024-06-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

SUPER BUGS Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_4581.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2024-06-18.

What are the main provisions?

Key points include:

  • Enhanced Health Security: Focuses on accelerating the development of products to combat pandemic-potential pathogens and superbugs, directly improving public health protection.
  • International Collaboration: Requires the U.S. government to enter into arrangements with foreign countries and multilateral organizations to jointly fund, develop, and distribute new medical countermeasures.
  • Efficient Resource Allocation: The strategy must ensure that scarce funds are allocated to projects with the greatest positive impact on human health, including through public-private partnerships and streamlined regulatory processes.
  • Addressing Superbugs: Specifically targets antimicrobial-resistant pathogens, aligning with existing U.S. biodefense and antibiotic resistance strategies.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Kelly, Mark [D-AZ].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health Security Economy